Literature DB >> 21049972

Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.

Gang Xia1, LeeAnn J Boerma, Bryan D Cox, Cheng Qiu, Sebyung Kang, Craig D Smith, Matthew B Renfrow, Donald D Muccio.   

Abstract

Retinoid X receptors (RXRs) are ligand-dependent nuclear receptors, which are activated by the potent agonist 9-cis-retinoic acid (9cRA). 9cRA binds to the ligand binding domain (LBD) of RXRs and recruits coactivator proteins for gene transcription. Using isothermal titration calorimetry, the binding of a 13-mer coactivator peptide, GRIP-1, to the hRXRα-LBD homodimer complex containing 9cRA (hRXRα-LBD:9cRA:GRIP-1) is reported between 20 and 37 °C. ΔG is temperature independent (-8.5 kcal/mol), and GRIP-1 binding is driven by ΔH (-9.2 kcal/mol) at 25 °C. ΔC(p) is large and negative (-401 cal mol(-1) K(-1)). The crystal structure of hRXRα-LBD:9cRA:GRIP-1 is reported at 2.05 Å. When the structures of hRXRα-LBD:9cRA:GRIP-1 and hRXRα-LBD:9cRA ( 1FBY ) homodimers are compared, E453 and E456 on helix 12 bury and form ionic interactions with GRIP-1. R302 on helix 4 realigns to form new salt bridges to both E453 and E456. F277 (helix 3), F437 (helix 11), and F450 (helix 12) move toward the hydrophobic interior. The changes in the near-UV spectrum at 260 nm of the hRXRα-LBD:9cRA:GRIP-1 support this structural change. Helix 11 tilts toward helix 12 by ≈1 Å, modifying the ring conformation of 9cRA. Hydrogen-deuterium exchange mass spectroscopy indicates GRIP-1 binding to hRXRα-LBD:9cRA significantly decreases the exchange rates for peptides containing helices 3 (F277), 4 (R302), 11 (F437), and 12 (E453, E456). The structural changes and loss of dynamics of the GRIP-1-bound structure are used to interpret the energetics of coactivator peptide binding to the agonist-bound hRXRα-LBD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049972      PMCID: PMC3081989          DOI: 10.1021/bi101288y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domain.

Authors:  Wen-yi Lee; Noa Noy
Journal:  Biochemistry       Date:  2002-02-26       Impact factor: 3.162

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

4.  The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

Authors:  Kelly Suino; Li Peng; Ross Reynolds; Yong Li; Ji-Young Cha; Joyce J Repa; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

5.  Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.

Authors:  Virginie Nahoum; Efrén Pérez; Pierre Germain; Fátima Rodríguez-Barrios; Fabio Manzo; Sabrina Kammerer; Geraldine Lemaire; Oliver Hirsch; Catherine A Royer; Hinrich Gronemeyer; Angel R de Lera; William Bourguet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-18       Impact factor: 11.205

6.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

Review 7.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

8.  Estimation of changes in side chain configurational entropy in binding and folding: general methods and application to helix formation.

Authors:  K H Lee; D Xie; E Freire; L M Amzel
Journal:  Proteins       Date:  1994-09

9.  Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry.

Authors:  Xuguang Yan; David Broderick; Mark E Leid; Michael I Schimerlik; Max L Deinzer
Journal:  Biochemistry       Date:  2004-02-03       Impact factor: 3.162

10.  The Deuterator: software for the determination of backbone amide deuterium levels from H/D exchange MS data.

Authors:  B D Pascal; M J Chalmers; S A Busby; C C Mader; M R Southern; N F Tsinoremas; P R Griffin
Journal:  BMC Bioinformatics       Date:  2007-05-16       Impact factor: 3.169

View more
  12 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors.

Authors:  Judit Osz; Yann Brélivet; Carole Peluso-Iltis; Vincent Cura; Sylvia Eiler; Marc Ruff; William Bourguet; Natacha Rochel; Dino Moras
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

3.  Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

Authors:  Liping Yang; David Broderick; Yuan Jiang; Victor Hsu; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2014-06-18

4.  Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.

Authors:  Anil Desphande; Gang Xia; LeeAnn J Boerma; Kimberly K Vines; Venkatram R Atigadda; Susan Lobo-Ruppert; Clinton J Grubbs; Fariba L Moeinpour; Craig D Smith; Konstantin Christov; Wayne J Brouillette; Donald D Muccio
Journal:  Bioorg Med Chem       Date:  2013-12-01       Impact factor: 3.641

Review 5.  Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions.

Authors:  Michael J Chalmers; Scott A Busby; Bruce D Pascal; Graham M West; Patrick R Griffin
Journal:  Expert Rev Proteomics       Date:  2011-02       Impact factor: 3.940

6.  Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.

Authors:  Venkatram R Atigadda; Gang Xia; Anil Deshpande; Lizhi Wu; Natalia Kedishvili; Craig D Smith; Helen Krontiras; Kirby I Bland; Clinton J Grubbs; Wayne J Brouillette; Donald D Muccio
Journal:  J Med Chem       Date:  2015-09-22       Impact factor: 7.446

7.  Development of a Magnetic Microbead Affinity Selection Screen (MagMASS) Using Mass Spectrometry for Ligands to the Retinoid X Receptor-α.

Authors:  Michael D Rush; Elisabeth M Walker; Gerd Prehna; Tristesse Burton; Richard B van Breemen
Journal:  J Am Soc Mass Spectrom       Date:  2016-12-13       Impact factor: 3.109

8.  Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA.

Authors:  Ian Mitchelle S de Vera; Jie Zheng; Scott Novick; Jinsai Shang; Travis S Hughes; Richard Brust; Paola Munoz-Tello; William J Gardner; David P Marciano; Xiangming Kong; Patrick R Griffin; Douglas J Kojetin
Journal:  Structure       Date:  2017-09-07       Impact factor: 5.006

9.  Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.

Authors:  Leeann J Boerma; Gang Xia; Cheng Qui; Bryan D Cox; Michael J Chalmers; Craig D Smith; Susan Lobo-Ruppert; Patrick R Griffin; Donald D Muccio; Matthew B Renfrow
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

10.  Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.

Authors:  Venkatram R Atigadda; Gang Xia; Anil Desphande; LeeAnn J Boerma; Susan Lobo-Ruppert; Clinton J Grubbs; Craig D Smith; Wayne J Brouillette; Donald D Muccio
Journal:  J Med Chem       Date:  2014-06-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.